PanAgora Asset Management »

Tscan Therapeutics shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $25k 25k 1.00

More positions owned by PanAgora Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Philip Morris International (PM)
JPMorgan Chase & Co. (JPM)
Synchrony Financial (SYF)
McKesson Corporation (MCK)

View all positions for PanAgora Asset Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Group
BlackRock
Standard Life Aberdeen
Deer Management
Renaissance Technologies
DC Funds
Geode Capital Management
Millennium Management
Two Sigma Investments
Citadel Advisors
Jane Street
Marshall Wace

View all funds holding Tscan Therapeutics